Article
The current state of Cytotherapy and the field of cell and gene therapy
11 Feb 2025
Abstract excerpt
2024 marked a transformative phase for cell and gene therapy (CGT) with significant advancements in scientific innovation, regulatory approvals and commercialization milestones. This review highlights key developments in CGT, including innovations in chimeric antigen receptor (CAR)-T therapies, mesenchymal stromal cells (MSCs), gene editing and regenerative medicine, alongside challenges in scalability,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
